Ineos appoints Wood as partner for its new petrochemicals project in Antwerp

July 3, 2019

Wood has been appointed program management partner for the duration of the project and will oversee the execution of the new petrochemicals complex, situated in Antwerp, Belgium.
Effective immediately, the contract will be delivered by the company’s multi-disciplinary capital projects team based in Reading, UK and at the site in Antwerp. Dave Stewart, CEO of Wood’s Asset Solutions business in Europe, Africa, Asia & Australia, comments: “We are delighted to support INEOS as part of an integrated project management partnership to deliver this strategically important development for the European petrochemicals industry. “We will bring our renowned project management capability in delivering large-scale capital projects and extensive track record of providing engineering, procurement and construction services globally, to this contract. “This award adds to our downstream portfolio in the region and highlights our commitment to growing our petrochemicals business by utilising our wealth of engineering and operational expertise to help customers design, build, run and improve refining and chemical plants.”

Spotlight

Fidia Farmaceutici SpA

Privately held, fully integrated Italian pharmaceutical company, with R&D, manufacturing, marketing, and sales capabilities. Fidia Farmaceutici S.p.A founded in Bologna (Italy) in 1946 and relocated to Abano Terme (Italy) in 1959, is part of the P & R Group since 1999, ranked among the top ten national chemical groups. The Group counts more than 1.800 employees, distributed between the chemical and pharmaceutical market segments Fidia Farmaceutici S.p.A. and its associated companies operate worldwide with the aim of developing and marketing innovative healthcare products (medicinal products, medical devices, and dietary supplements), primarily based on proprietary hyaluronic acid (HA) and its derivatives. More than fifty years of research into this molecule have placed Fidia at the forefront in the production of both natural and functionalized hyaluronic acid, utilizing proprietary and validated extraction and biotech processes. Fidia is continually working to identify new opportunitie

OTHER ARTICLES

Transporting biological and chemical materials - what you need to know

Article | February 13, 2020

The landscape of biological and chemical logistics has changed rapidly - as have the regulatory frameworks around it. What has not necessarily kept pace is the end-user understanding of the nature of these logistical processes, their opportunities and their constraints. Twenty years ago, the transmission of biological and chemical materials was limited to a small range of organisations: usually national and international research companies, hospitals, major university departments, police and military departments with forensic responsibilities.

Read More

Setting record straight on testing harm in chemicals

Article | February 13, 2020

The modern world is built on chemicals, be it the medicines we use, or cleaning fluids, crop protection products, or the raw materials for everything from laptops and mobile phones to clothes and furniture. Across all, we have created an entire modern society with chemicals, and, as a result, constantly stretched the size of the world population we can feed, clothe and shelter. Yet, balancing all the gains from the modern chemistry around us against any negative environmental and human impact has been a rising concern, making for ever greater focus on testing and on risk assessment.

Read More

Why chemical characterization is the best way to assess patient risk

Article | February 11, 2020

Everyone is very familiar with the phrase when buying a house: All that really matters are three things - location, location, and location. This same principle applies to extractables and leachables chemistry analysis – the three things that truly matter are identification, identification, and identification. The greatest growth in the past ten years in demonstrating the safety of medical devices and container closure systems for drugs has been using analytical chemistry to determine what chemicals can leach from the device and what the patient is exposed to during its intended use.

Read More

How Chemical Companies Benefit from the Experience Economy

Article | February 10, 2020

To feel or experience from a business engagement started with customer experience mainly in the consumer products business. Today it has extended to even knowledge industries like the chemical industry where experiencing or feeling can be leveraged to include all stake holders from customers primarily to employees to supply chain people & suppliers and all else. With digital technologies this has become easier than before. The benefits from promoting the ‘feel’ or ‘experience’ emotion could be multifarious for the chemical industry as described in this article.

Read More

Spotlight

Fidia Farmaceutici SpA

Privately held, fully integrated Italian pharmaceutical company, with R&D, manufacturing, marketing, and sales capabilities. Fidia Farmaceutici S.p.A founded in Bologna (Italy) in 1946 and relocated to Abano Terme (Italy) in 1959, is part of the P & R Group since 1999, ranked among the top ten national chemical groups. The Group counts more than 1.800 employees, distributed between the chemical and pharmaceutical market segments Fidia Farmaceutici S.p.A. and its associated companies operate worldwide with the aim of developing and marketing innovative healthcare products (medicinal products, medical devices, and dietary supplements), primarily based on proprietary hyaluronic acid (HA) and its derivatives. More than fifty years of research into this molecule have placed Fidia at the forefront in the production of both natural and functionalized hyaluronic acid, utilizing proprietary and validated extraction and biotech processes. Fidia is continually working to identify new opportunitie

Events